RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
| Condition(s) | Migraine, Migraine With Aura, Migraine Without Aura |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients. |
| Who can participate | Inclusion Criteria: * Diagnosis of migraine without aura or migraine with aura, according to the 3rd edition of the International Classification of Headache Disorder (ICHD-III); * At least 4 monthly migraine days; * Good compliance to study procedures; * Availability of headache diary at least of the preceding months before enrollment. Exclusion Criteria: * Subjects with contraindications for use of gepants; * Diagnosis of chronic migraine * Concomitant diagnosis of medical diseases and/or comorbidities that, in the Investigator's opinion might interfere with study assessments; * medical comorbidities that could interfere with study results; * Pregnancy and breastfeeding. * Changes in preventive treatments in the month before the first administration of rimegepant |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Florence |
| Locations | Florence, Florence, Italy; Pavia, Pavia, Italy |
| Start date | 2024-03-26 |
| NCT ID | NCT06409832 |
| Official listing | https://clinicaltrials.gov/study/NCT06409832 |